Sort   by:  
 Page size 
UnknownManagement of adverse events associated with idelalisib treatment: expert panel opinion.
Not available
S-EPMC4732460 | biostudies-literature
UnknownCombinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma.
Not available
S-EPMC5737161 | biostudies-literature
UnknownIgH sequences in common variable immune deficiency reveal altered B cell development and selection.
Not available
S-EPMC4584259 | biostudies-literature
TranscriptomicsInfluenza peptide reactivity within a cohort of age-stratified individuals pre and post vaccination with the 2008/2009 trivalent influenza vaccine
The aim of the study was to test the hypothesis that peptide array reactivity will reveal patterns that can be associated with poor or effective neutralization response to seasonal influenza vaccine We diluted patient sera 1:80 and incubated dilutions on a streptavidin-coated glass surface that was ...
ORGANISM(S): Homo sapiens 
2013-05-01 | E-GEOD-43446 | biostudies-arrayexpress
UnknownIdelalisib and rituximab in relapsed chronic lymphocytic leukemia.
Not available
S-EPMC4161365 | biostudies-literature
UnknownExtended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.
Not available
S-EPMC5770586 | biostudies-literature
Sort   by:  
 Page size